{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:31:38Z","timestamp":1786555898012,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.therap.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T02:36:20Z","timestamp":1758508580000},"page":"349-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluoxetine-induced lower limb ecchymosis in an adolescent: A case report and literature review"],"prefix":"10.1016","volume":"81","author":[{"given":"Thomas","family":"Darque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Pruvot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sanchez-Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrtille","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.09.003_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2025.09.003_bib0075","series-title":"Fluox\u00e9tine\u00a0\u2013\u00a0r\u00e9sum\u00e9 des caract\u00e9ristiques du produit","year":"2025"},{"key":"10.1016\/j.therap.2025.09.003_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2025.09.003_bib0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2025.09.003_bib0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.therap.2025.09.003_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.therap.2025.09.003_bib0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0248-8663(00)88244-2","article-title":"Hemorrhagic syndromes related to selective serotine reuptake inhibitor antidepressants. Seven case reports and review of the literature","volume":"21","author":"Nelva","year":"2000","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2025.09.003_bib0105","first-page":"320","article-title":"Ecchymosis associated with the use of fluoxetine: case report","volume":"13","author":"Mirsal","year":"2002","journal-title":"Turk Psikiyatr Derg"},{"key":"10.1016\/j.therap.2025.09.003_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2006.08.013","article-title":"Ecchymoses as an adverse effect of fluoxetine treatment","volume":"152","author":"Fountoulakis","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.therap.2025.09.003_bib0115","first-page":"428","article-title":"Ecchymosis related fluoxetine in an adolescent girl with trichotillomania","volume":"17","author":"Eray","year":"2016","journal-title":"Anatol J Psychiatry"},{"key":"10.1016\/j.therap.2025.09.003_bib0120","first-page":"19","article-title":"A case of fluoxetine-induced lower extremity ecchymosis","author":"Cetin","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.therap.2025.09.003_bib0125","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/archinte.164.21.2367","article-title":"Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants","volume":"164","author":"Meijer","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.therap.2025.09.003_bib0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0033-3182(96)71592-X","article-title":"Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors","volume":"37","author":"Skop","year":"1996","journal-title":"Psychosomatic"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572500109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572500109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:36:32Z","timestamp":1786552592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059572500109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S004059572500109X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.09.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoxetine-induced lower limb ecchymosis in an adolescent: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}